FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Cipla USA Inc.,)

View source ↗

Summary

FDA approved a supplemental application for atorvastatin calcium submitted by Cipla USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)